Total synthesis and evaluation of C25-benzyloxyepothilone C for tubulin assembly and cytotoxicity against MCF-7 breast cancer cells

Department of Medicinal Chemistry, University of Kansas, 1251 Wescoe Hall Drive, Lawrence, KS 66045, USA.
Bioorganic & medicinal chemistry letters (Impact Factor: 2.42). 10/2008; 18(17):4904-6. DOI: 10.1016/j.bmcl.2008.07.024
Source: PubMed


The total synthesis of C25-benzyloxy epothilone C is described. A sequential Suzuki-Aldol-Yamaguchi macrolactonization strategy was utilized employing a novel derivatized C8-C12 fragment. The C25-benzyloxy analog exhibited significantly reduced biological activity in microtubule assembly and cytotoxicity assays. Molecular modeling simulations indicated that excessive steric bulk in the C25 position may reduce activity by disrupting key hydrogen bonds that are crucial for epothilone binding to beta-tubulin.

Download full-text


Available from: Ting-Lan Chiu, Jul 14, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Since the late 1990's, novel insights into molecular biology and carcinogenesis enabled the rational design of mechanism-based anticancer therapeutics. The large number of natural product (NP)-derived drugs currently under clinical evaluation and the recent approval of temsirolimus (Torisel) as a first mTOR protein kinase inhibitor indicate that NPs have to be considered not only as a seminal source of cytotoxic, but also as a source of molecularly targeted agents. Whereas molecular modeling is well established as an important and successful method to discover and rationalize bioactivities in medicinal chemistry research, its application has also proven to be also a powerful tool in the field of NPs. This review highlights the impact of computer-assisted approaches on NPs as molecularly targeted anticancer drugs. Examples of applications are provided focusing on innovative targets such as protein kinases, tumour vasculature, epigenetic modulators, heat shock protein (Hsp) 90, and direct apoptosis enhancers.
    No preview · Article · Mar 2010 · Current pharmaceutical design
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Each April there are a series of events internationally, nationally, and regionally promoting Public Health. The American Public Health Association celebrates National Public Health Week the first full week in April (www. Numerous states celebrate April as Public Health month (eg, North Carolina, Wash- ington). Although transient, these celebrations of the impor- tance of public health are most significant. However, these highlighting events do not adequately spotlight what else needs to be accomplished in this arena. The work of public health is a yearlong and demanding calling. The key chal- lenges and opportunities of public health research, applica- tion, and teaching need addressing by those with whom we work, collaborate, and conduct research within and beyond the academy. Small steps of success often herald the major cliffs yet to be surmounted. For example, the passage of health care reform legislation earlier this year was heralded by some who suggest immediate impacts upon public health as a result, while others suggest this bill is flawed and incom- plete in efforts to improve the health of the public. Perhaps (and unfortunately) both of these views are correct. Re- gardless, the major impacts of this legislation on the health care system and patients remain to be seen and may be decades away. Many challenges pertinent to public health surround us, and many solutions to dilemmas are being crafted by those in corridors and laboratories near and far. In an era when disciplinary focal distinctions are dissolving with collabo- rative efforts and funding agency requirements, can public health research — which by design and function is depen- dent upon many with varying credentials and degrees — be a major and crucial focal point for our academy? The answer is yes it can, it has been, and it will continue to be crucial.
    Full-text · Article · Jun 2010 · American journal of pharmaceutical education
  • Source

    Full-text · Article · Jun 2010 · American journal of pharmaceutical education
Show more